News | Drug Discovery and Development Centre (H3D)

H3D Open Day 2024

H3D would like to invite all undergrad and postgrad students in the science-related fields to the H3D Open Day, based at the University of Cape Town.

University of Cape Town’s H3D Centre Receives R5.5 million grant from the Technology Innovation Agency (TIA) towards state-of-the-art equipment to support critical research infrastructure

H3D receives critical funding to support ongoing research in the cause and treatment of infectious diseases in South Africa

The symposium is a pinnacle event for H3D, following the success of the previous four symposia held in Cape Town and Livingstone. The 5th H3D Symposium will be held at the prestigious Radisson Blu Mosi-Oa-Tunya Livingstone Resort in Zambia.

Honorary doctorate for Kelly Chibale in Switzerland

Leading University of Cape Town (UCT) scholar and scientist Professor Kelly Chibale has been awarded an honorary doctorate from the Faculty of Science at the University of Basel, Switzerland.

H3D Open Day 2023

H3D would like to invite all undergrad and postgrad students in the science-related fields to the H3D Open Day.

Kelly Chibale wins Royal Society Africa Prize 2023

Professor Kelly Chibale, who holds the Neville Isdell Chair in African-centric Drug Discovery and Development, and who is the director of the Holistic Drug Discovery and Development Centre (H3D) at the University of Cape Town (UCT), has bee

Major donation to develop tools and models for optimising medicines in African populations

The University of Cape Town’s (UCT) Holistic Drug Discovery and Development Centre (H3D) has received a donation of US$1.5 million from UCT alumnus and former chairperson and CEO of Coca-Cola Neville Isdell to continue the work of the Nevil

UCT funding to support cost-effective manufacturing of pharmaceuticals in South Africa

The manufacturing and availability of medicines in sub-Saharan Africa will receive a major boost with the injection of R13 million to the University of Cape Town’s (UCT) Holistic Drug Discovery and Development Centre (H3D).

In the Spotlight: Ending TB in Africa

This week H3D Centre’s Dr. Nashied Peton, Investigator, TB Biology, shares his take on the factors contributing to Africa’s high TB burden, and offers insights into what can be done to lower its prevalence on the continent.

Visit News Archive